The latest closing stock price for Corvus Pharmaceuticals as of September 19, 2024 is 5.61.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-606 today, roughly -1 times their original investment - a -11.00% compound annual growth rate over 8 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 6.15, which is 9.6% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.05, which is 81.3% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 2.16.
An investor who bought $1,000 worth of Corvus Pharmaceuticals stock at the IPO in 2016 would have $-606 today, roughly -1 times their original investment - a -11.00% compound annual growth rate over 8 years.
The all-time high Corvus Pharmaceuticals stock closing price was 21.37 on March 27, 2017.
The Corvus Pharmaceuticals 52-week high stock price is 6.15, which is 9.6% above the current share price.
The Corvus Pharmaceuticals 52-week low stock price is 1.05, which is 81.3% below the current share price.
The average Corvus Pharmaceuticals stock price for the last 52 weeks is 2.16.